(Q62662121)

1

0 references

author name string

E Guignouard

2

0 references

N Pedretti

3

0 references

M Garcia

4

0 references

A Delwail

5

0 references

F-X Bernard

6

0 references

F Nau

7

0 references

G Guillet

8

0 references

G Dagregorio

9

0 references

H Yssel

10

0 references

J-C Lecron

Clinical and Experimental Immunology

11

0 references

language of work or name

English

0 references

publication date

December 2007

0 references

published in

0 references

volume

150

0 references

issue

3

0 references

page(s)

407-15

0 references

cites work

Oncostatin M secreted by skin infiltrating T lymphocytes is a potent keratinocyte activator involved in skin inflammation

1 reference

12 December 2020

Cracking the cytokine code in psoriasis

1 reference

12 December 2020

Cloning and characterization of IL-10-related T cell-derived inducible factor (IL-TIF), a novel cytokine structurally related to IL-10 and inducible by IL-9.

1 reference

12 December 2020

Human interleukin-10-related T cell-derived inducible factor: molecular cloning and functional characterization as an hepatocyte-stimulating factor

1 reference

12 December 2020

Interleukin (IL)-22, a novel human cytokine that signals through the interferon receptor-related proteins CRF2-4 and IL-22R

1 reference

12 December 2020

Response of psoriasis to interleukin-10 is associated with suppression of cutaneous type 1 inflammation, downregulation of the epidermal interleukin-8/CXCR2 pathway and normalization of keratinocyte maturation.

1 reference

12 December 2020

Identification of the functional interleukin-22 (IL-22) receptor complex: the IL-10R2 chain (IL-10Rbeta ) is a common chain of both the IL-10 and IL-22 (IL-10-related T cell-derived inducible factor, IL-TIF) receptor complexes

1 reference

12 December 2020

Cloning and characterization of IL-22 binding protein, a natural antagonist of IL-10-related T cell-derived inducible factor/IL-22

1 reference

12 December 2020

Identification, cloning, and characterization of a novel soluble receptor that binds IL-22 and neutralizes its activity

1 reference

12 December 2020

A soluble class II cytokine receptor, IL-22RA2, is a naturally occurring IL-22 antagonist

1 reference

12 December 2020

Insights into psoriasis and other inflammatory diseases from large-scale gene expression studies

1 reference

12 December 2020

Acinar cells of the pancreas are a target of interleukin-22.

1 reference

12 December 2020

Cutting edge: immune cells as sources and targets of the IL-10 family members?

1 reference

12 December 2020

Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes

1 reference

12 December 2020

Interleukin-22 (IL-22) activates the JAK/STAT, ERK, JNK, and p38 MAP kinase pathways in a rat hepatoma cell line. Pathways that are shared with and distinct from IL-10.

1 reference

12 December 2020

T cell stimulation and expansion using anti-CD3/CD28 beads

1 reference

12 December 2020

S100 protein subcellular localization during epidermal differentiation and psoriasis

1 reference

12 December 2020

Interleukin-22 activates STAT3 and induces IL-10 by colon epithelial cells.

1 reference

12 December 2020

T cells in psoriatic lesional skin that survive conventional therapy with NB-UVB radiation display reduced IFN-gamma expression.

1 reference

12 December 2020

Psoriasis vulgaris: cutaneous lymphoid tissue supports T-cell activation and "Type 1" inflammatory gene expression

1 reference

12 December 2020

Characterization of human T cells that regulate neutrophilic skin inflammation.

1 reference

12 December 2020

IL-22 increases the innate immunity of tissues

1 reference

12 December 2020

Cytokines in skin lesions of psoriasis

1 reference

12 December 2020

The Cytokine Network in Lesional and Lesion-Free Psoriatic Skin Is Characterized by a T-Helper Type 1 Cell-Mediated Response

1 reference

12 December 2020

T cells involved in psoriasis vulgaris belong to the Th1 subset

1 reference

12 December 2020

IL-10 is a key cytokine in psoriasis. Proof of principle by IL-10 therapy: a new therapeutic approach

1 reference

12 December 2020

Interleukin 10 treatment of psoriasis: clinical results of a phase 2 trial

1 reference

12 December 2020

IL-22 inhibits epidermal differentiation and induces proinflammatory gene expression and migration of human keratinocytes

1 reference

12 December 2020

Psoriatic scales: a promising source for the isolation of human skin-derived antimicrobial proteins

1 reference

12 December 2020

Getting under the skin: the immunogenetics of psoriasis

1 reference

12 December 2020

The dynamics of gene expression of interleukin-19 and interleukin-20 and their receptors in psoriasis.

1 reference

12 December 2020

Keratinocytes as targets for interleukin-10-related cytokines: a putative role in the pathogenesis of psoriasis.

1 reference

12 December 2020

IL-22 regulates the expression of genes responsible for antimicrobial defense, cellular differentiation, and mobility in keratinocytes: a potential role in psoriasis

1 reference

12 December 2020

Expanding the effector CD4 T-cell repertoire: the Th17 lineage.

1 reference

12 December 2020

Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides

1 reference

12 December 2020

The pathogenic role of tissue-resident immune cells in psoriasis.

1 reference

12 December 2020

Interleukin-22, a T(H)17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis

1 reference

12 December 2020

Development, cytokine profile and function of human interleukin 17-producing helper T cells

1 reference

12 December 2020